Publications by authors named "Anne Gleizes"

Article Synopsis
  • Viral infections are a major cause of fever in young children in sub-Saharan Africa, but many causal viruses go undetected due to limited diagnostic capabilities in low-resource settings.
  • A study examined the blood virome of 816 febrile children under 5 in Dar es Salaam, revealing that about half had at least one virus known to cause human illness.
  • The research also identified several new, previously undocumented viruses that may be important for understanding pediatric fevers and tracking emerging health threats.
View Article and Find Full Text PDF
Article Synopsis
  • The genetic diversity of circulating viruses makes it difficult to diagnose emerging or rare viral diseases using traditional methods.
  • High-throughput technology presents a new opportunity for exploring the full range of viruses present in patients without bias, but it relies on a comprehensive and accurate reference dataset.
  • Virosaurus is a newly developed database that provides a non-biased collection of annotated viral sequences, facilitating clinical studies and including features like clustering to minimize redundancy and enhancing the representation of under-studied viruses, such as herpes and poxviruses.
View Article and Find Full Text PDF

The development of efficient text-mining tools promises to boost the curation workflow by significantly reducing the time needed to process the literature into biological databases. We have developed a curation support tool, neXtA5, that provides a search engine coupled with an annotation system directly integrated into a biocuration workflow. neXtA5 assists curation with modules optimized for the thevarious curation tasks: document triage, entity recognition and information extraction.

View Article and Find Full Text PDF

Background: Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated with a 60% lifetime risk for breast and ovarian cancer. This overall risk estimate is for all BRCA1 variants; obviously, not all variants confer the same risk of developing a disease. In cancer patients, loss of BRCA1 function in tumor tissue has been associated with an increased sensitivity to platinum agents and to poly-(ADP-ribose) polymerase (PARP) inhibitors.

View Article and Find Full Text PDF

The neXtProt human protein knowledgebase (https://www.nextprot.org) continues to add new content and tools, with a focus on proteomics and genetic variation data.

View Article and Find Full Text PDF

Motivation: Lipids are a large and diverse group of biological molecules with roles in membrane formation, energy storage and signaling. Cellular lipidomes may contain tens of thousands of structures, a staggering degree of complexity whose significance is not yet fully understood. High-throughput mass spectrometry-based platforms provide a means to study this complexity, but the interpretation of lipidomic data and its integration with prior knowledge of lipid biology suffers from a lack of appropriate tools to manage the data and extract knowledge from it.

View Article and Find Full Text PDF

neXtProt (http://www.nextprot.org) is a human protein-centric knowledgebase developed at the SIB Swiss Institute of Bioinformatics.

View Article and Find Full Text PDF

Combining epidemiological information, genetic characterization and geomapping in the analysis of influenza can contribute to a better understanding and description of influenza epidemiology and ecology, including possible virus reassortment events. Furthermore, integration of information such as agroecological farming system characteristics can provide new knowledge on risk factors of influenza emergence and spread. Integrating viral characteristics into an animal disease information system is therefore expected to provide a unique tool to trace-and-track particular virus strains; generate clade distributions and spatiotemporal clusters; screen for distribution of viruses with specific molecular markers; identify potential risk factors; and analyze or map viral characteristics related to vaccines used for control and/or prevention.

View Article and Find Full Text PDF

About 5000 (25%) of the ~20400 human protein-coding genes currently lack any experimental evidence at the protein level. For many others, there is only little information relative to their abundance, distribution, subcellular localization, interactions, or cellular functions. The aim of the HUPO Human Proteome Project (HPP, www.

View Article and Find Full Text PDF

neXtProt (http://www.nextprot.org/) is a new human protein-centric knowledge platform.

View Article and Find Full Text PDF

Although research on influenza lasted for more than 100 years, it is still one of the most prominent diseases causing half a million human deaths every year. With the recent observation of new highly pathogenic H5N1 and H7N7 strains, and the appearance of the influenza pandemic caused by the H1N1 swine-like lineage, a collaborative effort to share observations on the evolution of this virus in both animals and humans has been established. The OpenFlu database (OpenFluDB) is a part of this collaborative effort.

View Article and Find Full Text PDF

We present an integrated proteomics platform designed for performing differential analyses. Since reproducible results are essential for comparative studies, we explain how we improved reproducibility at every step of our laboratory processes, e.g.

View Article and Find Full Text PDF

Human blood plasma is a useful source of proteins associated with both health and disease. Analysis of human blood plasma is a challenge due to the large number of peptides and proteins present and the very wide range of concentrations. In order to identify as many proteins as possible for subsequent comparative studies, we developed an industrial-scale (2.

View Article and Find Full Text PDF

In a previous paper we introduced a novel model-based approach (OLAV) to the problem of identifying peptides via tandem mass spectrometry, for which early implementations showed promising performance. We recently further improved this performance to a remarkable level (1-2% false positive rate at 95% true positive rate) and characterized key properties of OLAV like robustness and training set size. We present these results in a synthetic and coherent way along with detailed performance comparisons, a new scoring component making use of peptide amino acidic composition, and new developments like automatic parameter learning.

View Article and Find Full Text PDF